C.H. Robinson Worldwide, Inc. (CHRW) Key Metrics
CHRW valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $16.27B
- Enterprise value
- $19.31B
- P/E (TTM)
- 26.6 10-yr median 22.7
- Forward P/E
- 21.5
- PEG ratio
- 1.82
- Price / sales
- 1.0 10-yr median 0.7
- Price / book
- 10.7 10-yr median 7.3
- EV / EBITDA
- 20.7 10-yr median 14.9
- Dividend yield
- 1.81% $2.52 a year
- Beta
- 0.95
CHRW key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCHRW valuation Price multiples at each fiscal year-end price.
CHRW returns How much profit the business earns on the capital it uses.
CHRW per-share figures Results divided by the shares outstanding at year-end.
CHRW financial health Debt, liquidity and how easily interest is covered.
CHRW efficiency & capital use Working capital cycle and where the cash goes.
CHRW valuation history
CHRW returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CHRW debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CHRW cash returned to shareholders
CHRW price vs earnings per share
CHRW key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $19.53B | $12.47B | $10.34B | $11.64B | $14.40B | $12.78B | $10.77B | $11.81B | $12.60B | $10.48B |
| Enterprise value | $21.00B | $14.06B | $12.15B | $13.79B | $16.37B | $13.97B | $11.88B | $12.77B | $13.73B | $11.47B |
| P/E ratio | 33.3 | 26.8 | 31.8 | 12.4 | 17.1 | 25.2 | 18.7 | 17.8 | 24.9 | 20.4 |
| Price / sales | 1.2 | 0.7 | 0.6 | 0.5 | 0.6 | 0.8 | 0.7 | 0.7 | 0.8 | 0.8 |
| Price / book | 10.6 | 7.2 | 7.3 | 8.6 | 7.1 | 6.8 | 6.4 | 7.4 | 8.8 | 8.3 |
| Price / free cash flow | 21.8 | 25.6 | 16.0 | 7.7 | 599.4 | 28.7 | 14.1 | 16.2 | 39.0 | 23.9 |
| Price / operating cash flow | 21.4 | 24.5 | 14.1 | 7.1 | 151.7 | 25.6 | 12.9 | 14.9 | 33.1 | 19.8 |
| EV / sales | 1.3 | 0.8 | 0.7 | 0.6 | 0.7 | 0.9 | 0.8 | 0.8 | 0.9 | 0.9 |
| EV / EBITDA | 23.6 | 18.4 | 19.8 | 10.1 | 14.0 | 18.0 | 13.3 | 12.7 | 15.8 | 12.6 |
| EV / free cash flow | 23.5 | 28.9 | 18.7 | 9.1 | 681.3 | 31.4 | 15.5 | 17.5 | 42.6 | 26.2 |
| Earnings yield | 3.0% | 3.7% | 3.1% | 8.1% | 5.9% | 4.0% | 5.4% | 5.6% | 4.0% | 4.9% |
| Free cash flow yield | 4.6% | 3.9% | 6.3% | 13.1% | 0.2% | 3.5% | 7.1% | 6.2% | 2.6% | 4.2% |
| Dividend yield | 1.5% | 2.4% | 2.8% | 2.5% | 1.9% | 1.6% | 2.6% | 2.2% | 2.1% | 2.3% |
| Shareholder yield (dividends + buybacks) | 3.4% | 2.6% | 3.4% | 15.2% | 6.1% | 3.2% | 5.6% | 4.8% | 3.5% | 4.0% |
| Share price at fiscal year-end | $160.76 | $103.32 | $86.39 | $91.56 | $107.63 | $93.87 | $78.20 | $84.09 | $89.09 | $73.26 |
| Per share | ||||||||||
| Revenue per share | $133.60 | $146.88 | $147.03 | $194.23 | $172.62 | $119.02 | $111.15 | $118.45 | $105.17 | $91.92 |
| Earnings per share | $4.83 | $3.86 | $2.72 | $7.40 | $6.31 | $3.72 | $4.19 | $4.73 | $3.57 | $3.59 |
| Operating cash flow per share | $7.53 | $4.22 | $6.12 | $12.98 | $0.71 | $3.67 | $6.07 | $5.65 | $2.69 | $3.70 |
| Free cash flow per share | $7.37 | $4.03 | $5.41 | $11.97 | $0.18 | $3.27 | $5.55 | $5.19 | $2.28 | $3.06 |
| Cash per share | $1.32 | $1.21 | $1.22 | $1.71 | $1.92 | $1.79 | $3.25 | $2.70 | $2.36 | $1.73 |
| Book value per share | $15.19 | $14.27 | $11.85 | $10.64 | $15.11 | $13.81 | $12.13 | $11.36 | $10.08 | $8.80 |
| Tangible book value per share | $2.30 | $1.37 | −$1.68 | −$2.13 | $2.82 | $1.61 | $1.72 | $1.37 | −$0.20 | −$1.19 |
| Dividends per share | $2.48 | $2.44 | $2.44 | $2.24 | $2.07 | $1.54 | $2.02 | $1.89 | $1.83 | $1.72 |
| Capex per share | $0.16 | $0.19 | $0.70 | $1.01 | $0.53 | $0.40 | $0.51 | $0.45 | $0.41 | $0.64 |
| Debt per share | $13.41 | $14.43 | $16.31 | $18.57 | $16.64 | $10.49 | $11.30 | $9.59 | $10.36 | $8.67 |
| Shares outstanding | 121.5M | 120.7M | 119.7M | 127.2M | 133.8M | 136.2M | 137.7M | 140.4M | 141.4M | 143.0M |
| Change in shares outstanding | +0.7% | +0.8% | −5.9% | −5.0% | −1.7% | −1.1% | −1.9% | −0.7% | −1.1% | −1.6% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 32.9% | 29.7% | 23.5% | 55.7% | 43.3% | 28.5% | 35.3% | 44.0% | 37.6% | 42.9% |
| Return on invested capital (ROIC) | 19.5% | 16.4% | 12.2% | 27.3% | 25.3% | 18.6% | 23.0% | 26.9% | 22.4% | 25.4% |
| Return on assets (ROA) | 11.3% | 8.9% | 5.8% | 14.5% | 13.9% | 10.4% | 12.7% | 15.3% | 12.8% | 15.0% |
| Return on tangible assets | 16.8% | 12.4% | 9.0% | 21.7% | 15.7% | 14.5% | 18.0% | 22.0% | 18.2% | 23.1% |
| Free cash flow margin | 5.5% | 2.7% | 3.7% | 6.2% | 0.1% | 2.7% | 5.0% | 4.4% | 2.2% | 3.3% |
| Income quality (OCF / net income) | 1.56 | 1.09 | 2.25 | 1.75 | 0.11 | 0.99 | 1.45 | 1.19 | 0.75 | 1.03 |
| Financial health | ||||||||||
| Total debt | $1.63B | $1.74B | $1.95B | $2.36B | $2.23B | $1.43B | $1.56B | $1.35B | $1.47B | $1.24B |
| Cash & short-term investments | $160.9M | $145.8M | $145.5M | $217.5M | $257.4M | $243.8M | $447.9M | $378.6M | $333.9M | $247.7M |
| Net debt | $1.47B | $1.60B | $1.81B | $2.14B | $1.97B | $1.18B | $1.11B | $967.7M | $1.13B | $992.3M |
| Debt / equity | 0.88 | 1.01 | 1.38 | 1.74 | 1.10 | 0.76 | 0.93 | 0.84 | 1.03 | 0.99 |
| Debt / assets | 0.32 | 0.33 | 0.37 | 0.40 | 0.32 | 0.28 | 0.34 | 0.30 | 0.35 | 0.34 |
| Net debt / EBITDA | 1.65 | 2.08 | 2.94 | 1.58 | 1.68 | 1.53 | 1.24 | 0.96 | 1.30 | 1.09 |
| Current ratio | 1.53 | 1.28 | 1.40 | 1.08 | 1.44 | 1.60 | 1.70 | 1.92 | 1.26 | 1.09 |
| Quick ratio | 1.53 | 1.28 | 1.40 | 1.08 | 1.58 | 1.71 | 1.78 | 1.92 | 1.26 | 1.09 |
| Interest coverage | 12.6 | 7.4 | 4.9 | 12.7 | 18.1 | 15.0 | 16.6 | 28.7 | 16.6 | 32.7 |
| Working capital | $966.8M | $644.7M | $828.7M | $266.4M | $1.48B | $1.10B | $1.08B | $1.32B | $523.5M | $162.4M |
| Invested capital | $3.31B | $3.32B | $3.23B | $3.50B | $3.99B | $3.06B | $2.78B | $2.56B | $2.56B | $2.25B |
| Tangible asset value | $279.2M | $165.5M | −$201.1M | −$270.2M | $377.5M | $219.2M | $236.3M | $192.7M | −$28.4M | −$169.8M |
| Net current asset value | −$414.2M | −$606.3M | −$925.9M | −$1.01B | −$202.0M | −$322.6M | −$330.2M | −$79.3M | −$299.2M | −$421.8M |
| Graham number | $40.64 | $35.20 | $26.92 | $42.09 | $46.31 | $33.99 | $33.81 | $34.78 | $28.47 | $26.66 |
| Graham net-net per share | −$9.58 | −$12.36 | −$14.47 | −$15.31 | −$12.42 | −$8.33 | −$7.32 | −$5.07 | −$6.30 | −$6.04 |
| Capital allocation | ||||||||||
| Dividends paid | $301.4M | $294.8M | $291.6M | $285.3M | $277.3M | $210.0M | $277.8M | $265.2M | $258.2M | $245.4M |
| Share buybacks (net) | $354.7M | $32.2M | $63.9M | $1.49B | $608.5M | $195.4M | $324.6M | $301.0M | $185.5M | $172.9M |
| Dividend payout ratio | 51.3% | 63.3% | 89.7% | 30.3% | 32.8% | 41.5% | 48.1% | 39.9% | 51.1% | 47.8% |
| Dividends + buybacks / free cash flow | 73.3% | 67.2% | 54.9% | 116.6% | — | 91.0% | 78.7% | 77.7% | 137.6% | 95.5% |
| Capex / revenue | 0.1% | 0.1% | 0.5% | 0.5% | 0.3% | 0.3% | 0.5% | 0.4% | 0.4% | 0.7% |
| Capex / operating cash flow | 2.1% | 4.4% | 11.5% | 7.8% | 74.7% | 10.8% | 8.4% | 8.1% | 15.2% | 17.3% |
| Capex / depreciation | 0.19 | 0.23 | 0.85 | 1.39 | 0.78 | 0.53 | 0.70 | 0.66 | 0.62 | 1.22 |
| Stock-based compensation / revenue | 0.5% | 0.5% | 0.3% | 0.4% | 0.6% | 0.3% | 0.3% | 0.5% | 0.3% | 0.3% |
| R&D / revenue | — | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | — | — |
| SG&A / revenue | 3.5% | 3.6% | 3.7% | 2.4% | 2.3% | 3.1% | 3.3% | 2.7% | 2.8% | 2.9% |
| Efficiency | ||||||||||
| Days sales outstanding | 57.4 | 53.1 | 60.4 | 56.7 | 55.8 | 53.5 | 52.8 | 48.7 | 46.9 | 44.7 |
| Days of inventory on hand | — | — | — | -3.6 | -5.5 | -4.0 | -1.7 | 0.0 | 0.0 | — |
| Days payables outstanding | 30.1 | 28.0 | 30.7 | 26.2 | 25.5 | 26.5 | 25.5 | 23.6 | 24.5 | 23.5 |
| Cash conversion cycle (days) | 27.2 | 25.1 | 29.6 | 26.8 | 24.7 | 23.1 | 25.6 | 25.1 | 22.4 | 21.1 |
| Receivables turnover | 6.36 | 6.88 | 6.05 | 6.44 | 6.54 | 6.82 | 6.91 | 7.50 | 7.77 | 8.17 |
| Payables turnover | 12.12 | 13.05 | 11.88 | 13.92 | 14.29 | 13.80 | 14.34 | 15.49 | 14.87 | 15.52 |
| Inventory turnover | — | — | — | — | — | — | — | 15,269,479,000.00 | 27,361,714,000.00 | — |
| Asset turnover | 3.13 | 3.37 | 3.15 | 3.80 | 3.80 | 3.31 | 3.38 | 3.84 | 3.77 | 3.85 |
| Average receivables | $2.55B | $2.58B | $2.91B | $3.83B | $3.53B | $2.38B | $2.21B | $2.22B | $1.91B | $1.61B |
| Average payables | $1.23B | $1.26B | $1.39B | $1.64B | $1.50B | $1.09B | $977.8M | $985.7M | $920.0M | $768.7M |
| Average inventory | — | — | — | −$226.8M | −$325.4M | −$165.0M | −$66.4M | $1 | $0 | $0 |
| Intangibles / total assets | 31.0% | 29.4% | 31.0% | 27.3% | 23.4% | 32.3% | 30.9% | 31.7% | 34.3% | 39.1% |
Computed from CHRW's annual financial statements (latest annual report filed February 13, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CHRW valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), C.H. Robinson traded at 33.3 times earnings, against a 10-year median of 22.7. Based on the latest twelve months, the trailing P/E is 26.6 and the forward P/E is 21.5. C.H. Robinson earned a return on equity of 32.9% and a return on invested capital of 19.5% in fiscal 2025. It ended the year with $1.6 billion of debt and $160.9 million in cash and short-term investments, net debt of $1.5 billion. It returned $656.0 million to shareholders: $301.4 million in dividends and $354.7 million in share buybacks, 73% of free cash flow. The share count fell 15.0% from 143.0M to 121.5M over 9 years.
See the CHRW income statement, the CHRW chart for price history, or the CHRW stock overview for the latest quote and news.
CHRW key metrics FAQ
What is C.H. Robinson's P/E ratio?
C.H. Robinson's trailing P/E ratio is 26.6 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 21.5. At the end of fiscal 2025 it was 33.3, compared with a 10-year median of 22.7.
What is C.H. Robinson's EV/EBITDA?
C.H. Robinson's enterprise value was 23.6 times EBITDA at the end of fiscal 2025 (enterprise value $21.0 billion, EBITDA $888.4 million); the current EV/EBITDA is 20.7.
What is C.H. Robinson's return on equity?
C.H. Robinson's return on equity (ROE) was 32.9% in fiscal 2025: net income of $587.1 million on average shareholders' equity of $1.8 billion.
What is C.H. Robinson's ROIC?
C.H. Robinson's return on invested capital was 19.5% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does C.H. Robinson have?
C.H. Robinson had total debt of $1.6 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.88 and $1.5 billion of net debt (1.65 times EBITDA).
What is C.H. Robinson's dividend yield?
C.H. Robinson's forward dividend yield is 1.81%. C.H. Robinson paid $301.4 million in dividends in fiscal 2025 ($2.48 per share), a payout ratio of 51.3%.
Does C.H. Robinson buy back its shares?
Yes. C.H. Robinson spent $354.7 million on net share repurchases in fiscal 2025 Shares outstanding changed +0.7% over the year, to 121.5M..
What is C.H. Robinson's free cash flow yield?
C.H. Robinson generated $894.9 million of free cash flow in fiscal 2025, a free cash flow yield of 4.6% on its market value at year-end ($19.5 billion).
What is C.H. Robinson's current ratio?
C.H. Robinson's current ratio was 1.53 at the end of fiscal 2025: current assets were 1.53 times current liabilities.